CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well CCI-779 works in treating patients with relapsed or
refractory chronic lymphocytic leukemia. Drugs used in chemotherapy, such as CCI-779, work in
different ways to stop cancer cells from dividing so they stop growing or die